← Evidence map

ArticleBritish journal of cancer2005

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy.

F Barlési et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

this paperpooled itcites it

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy. | OpenQuestion